Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

The FSHD Composite Outcome Measure (FSHD-COM) is Reliable, Valid, and Measures Disease Progression

Author:Eichinger, Katy   McDermott, Michael   Higgs, Kiley   Walker, Michaela   Lewis, Leann   Martens, William   Leung, Doris   Stinson, Nikia   Holzer, Megan M   Sacconi, Sabrina   Garcia, Jeremy   De Paz Benito, Victor   Mul, Karlien   Sansone, Valeria   Carraro, Elena   Becchiati, Stefano   Frisoni, Maria Chiara   Wang, Leo   Kieu, Catherine   Shieh, Perry   Skura, Christy   Elsheikh, Bakri   Kelly, Kristina   Jaworek, Andrea   LoRusso, Samantha   Butterfield, Russell   Wilson, Amelia   McIntyre, Melissa   Johnson, Nicholas   Butler, Amanda   Jones, Aileen   Hayes, Melissa   Baker, Lindsay   Sasidharan, Sandhya   Tawil, Alrabi   Statland, Jeffrey   

Session Name:S7: Outcome Measures and Observational Studies of Neuromuscular Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.005  

Author Institution:University of Rochester Medical Center, Rochester, NY  University of Kansas Medical Center, Kansas City, KS  University of Kansas Medical Center, Fairway, KS  Kennedy Krieger Institute, Baltimore, MD  Nice University, Nice, France  Radboud University, Nijmegen, Netherlands  The NEMO Clinical Center - Neurorehabilitation Unit, University of Milan, Milan, Italy  University of Washington, Seattle, WA  UCLA, Los Angeles, CA  The Ohio State University Wexner Medical Center, Columbus, OH  Kaiser, Lone Tree, CO  University of Utah, Salt Lake City, UT  Virginia Commonwealth University, Richmond, VA  

Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories

Author:Gross, Catharina C   Schulte-Mecklenbeck, Andreas   Steinberg, Olga V   Wirth, Timo   Lauks, Sarah   Baranzini, Sergio E   Bittner, Stefan   Bellmann-Strobl, Judith   Bünger, Nora   Eilers, Eva   Eveslage, Maria   Fleischer, Vinzenz   Gisevius, Barbara   Groppa, Sergiu   Haas, Jürgen   Kerschensteiner, Martin   Kirstein, Lucienne   Korsukewitz, Catharina   Lohmann, Lisa   Lünemann, Jan   Lüssi, Felix   Meyer zu Hörste, Gerd   Motte, Jeremias   Ruck, Tobias   Schwab, Nicholas   Meuth, Sven G   Paul, Friedemann   Wildemann, Brigitte   Kümpfel, Tania   Gold, Ralf   Zipp, Frauke   Klotz, Luisa   Wiendl, Heinz   

Session Name:P1: MS Biomarkers  

Topic:MS and Inflammatory Disease  

Program Number:P1.008  

Author Institution:University Hospital Münster, Münster, Germany  University of California San Francisco, San Francisco, CA  University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany  Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Berlin, Germany  University of Münster, Münster, Germany  University Hospital Bochum, Bochum, Germany  University of Heidelberg, Heidelberg, Germany  Ludwig Maximilians University of Munich, Munich, Germany  University and University Hospital of Münster, Münster, Germany  Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany  Charite Universitatsmedizin in Berlin, Berlin, Germany  University Hospital Heidelberg, Heidelberg, Germany